相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reproducible and Interpretable Spiculation Quantification for Lung Cancer Screening
Wookjin Choi et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2021)
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Davide Franceschini et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2020)
Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms
Jingjing Kang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Combining Immunotherapy with Radiation Therapy in Non- Small Cell Lung Cancer
Kelly Fitzgerald et al.
THORACIC SURGERY CLINICS (2020)
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping
Alex Zwanenburg et al.
RADIOLOGY (2020)
Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis
Corey C. Foster et al.
LUNG CANCER (2019)
Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer
Wen Yu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy
Luxi Ye et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)
Technical Note: Extension of CERR for computational radiomics: A comprehensive MATLAB platform for reproducible radiomics research
Aditya P. Apte et al.
MEDICAL PHYSICS (2018)
Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy
Jonathan E. Leeman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer
Vivek Verma et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy
Qian Li et al.
MEDICAL PHYSICS (2017)
7-Year Follow-Up After Stereotactic Ablative Radiotherapy for Patients With Stage I Non-Small Cell Lung Cancer: Results of a Phase 2 Clinical Trial
Bing Sun et al.
CANCER (2017)
Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer: Implications for Surveillance
Daniel E. Spratt et al.
CLINICAL LUNG CANCER (2016)
18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer
Charline Lasnon et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy
Pierre Lovinfosse et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months
Arturo Navarro-Martin et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation
Floris H. P. van Velden et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer
Elizabeth Huynh et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Radiomics of Lung Nodules: A Multi-Institutional Study of Robustness and Agreement of Quantitative Imaging Features
Jayashree Kalpathy-Cramer et al.
TOMOGRAPHY (2016)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
Karel G. M. Moons et al.
ANNALS OF INTERNAL MEDICINE (2015)
Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model
Alexander V. Louie et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403
Yasushi Nagata et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET
Jianhua Yan et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
Joe Y. Chang et al.
LANCET ONCOLOGY (2015)
FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer
Zachary A. Kohutek et al.
LUNG CANCER (2015)
Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy
Takaya Yamamoto et al.
RADIATION ONCOLOGY (2015)
Imaging Features Associated With Disease Progression After Stereotactic Ablative Radiotherapy for Stage I Non-Small-Cell Lung Cancer
David B. Shultz et al.
CLINICAL LUNG CANCER (2014)
Impact of Pretreatment Tumor Growth Rate on Outcome of Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
Soha Atallah et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Pretreatment [18F]-fluoro-2-deoxy-glucose Positron Emission Tomography Maximum Standardized Uptake Value as Predictor of Distant Metastasis in Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy: Rethinking the Role of Positron Emission Tomography in Personalizing Treatment Based on Risk Status
Vimoj J. Nair et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Tumor Texture Analysis in 18F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis
Fanny Orlhac et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
Zachary D. Horne et al.
RADIATION ONCOLOGY (2014)
Volume-based Parameters Measured by Using FDG PET/CT in Patients with Stage I NSCLC Treated with Stereotactic Body Radiation Therapy: Prognostic Value
Yoko Satoh et al.
RADIOLOGY (2014)
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis
Sashendra Senthi et al.
LANCET ONCOLOGY (2012)
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
Joe Y. Chang et al.
RADIATION ONCOLOGY (2012)
Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome?
Katy Clarke et al.
RADIOTHERAPY AND ONCOLOGY (2012)
The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT)
Atsuya Takeda et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Outcomes After Stereotactic Lung Radiotherapy or Wedge Resection for Stage I Non-Small-Cell Lung Cancer
Inga S. Grills et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
CERR: A computational environment for radiotherapy research
JO Deasy et al.
MEDICAL PHYSICS (2003)
分享论文
